Project Grant HT94252510888
Award Date
8/15/25
Completion Date
8/14/29
Dollars Obligated
$1.7M
Federal Agency
Defense Health Agency
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
The Yale University was awarded a $2.6 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The four-year award will support research exploring protein quality control dysfunction in dystonia from August 2021 through August 2025. Through this funding, Yale University researchers will investigate medical solutions for neurological disorders like dystonia, with the aim of transforming healthcare for service members and...
This $460,279 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research on "Loss of Proteostasis and Vascular Amyloidosis" at Yale University. The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions for the battlefield and addressing critical health challenges. The 2-year grant,...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
The federal Project Grant award of $999,965.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Yale University to investigate the role of the TDP-43 protein in trauma-associated Alzheimer's disease related dementia. The project aims to advance understanding of the protein dynamics underlying this condition, with the potential to transform healthcare for military service members, veterans, and the broader...
This federal Project Grant award for $859,773.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at Yale University aimed at transforming healthcare for military service members, veterans, and the broader public. The research project focuses on investigating biomarkers and targets of leptomeningeal disease progression from non-small cell lung cancer brain metastasis. The award has a performance...
Yale University received a $1,351,106 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award beginning July 1, 2023 will support research to identify circuit mechanisms of MDMA and methylone in order to develop plasticity-based post-traumatic stress disorder (PTSD) treatment. Through this funding, Yale researchers will investigate medical solutions applicable to battlefield conditions by...
The U.S. Department of Defense's Defense Health Agency awarded a $1,235,447 Project Grant to Yale University on July 1, 2023. This 3-year grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research targeting the chromatin regulator WDR5 to treat breast cancer metastasis. The project aims to transform health care for service members and the general public through innovative and impactful biomedical research investigating medical solutions for the...
This Project Grant award from the Defense Health Agency provides $3,354,829 to Duke University under the Military Medical Research and Development program (CFDA 12.420) to support drug development for dystonia. Duke will conduct research and collect biosamples from patients diagnosed with two forms of dystonia and from veteran and non-veteran populations. The University of Florida and Massachusetts General Hospital will serve as sub-awardees, with UF collecting blood samples from 50 patients...
This Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The $837,497 award to Yale University will fund research to investigate how "feeding stress primes the pancreas for cancer" over a performance period from November 1, 2024 to October 31, 2027. The grant supports...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,671,258.00 to Yale University to develop engineering-based neuronal-specific therapeutic mRNA treatments for Rett syndrome. The project aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical research to address critical health challenges. The research, conducted at Yale University over...